Home › NCT04699305

Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers

An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical Centers

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Subject is ≥18 years of age
* Subject has an exuding cutaneous wound
* Subject agrees to the use of his health data, including photos of his wound in analysis and publications
* Subject/LAR must be able to read and understand English and/or Spanish

Exclusion Criteria:

* Subject/LAR is unable to read and understand English or Spanish.

About the study

Multicenter observational study to explore the efficacy of ActiGraft in the treatment of exuding cutaneous wounds in real-life usage.

What is being tested

• ActiGraft (device)

Sponsor: RedDress Ltd. · Participants: 500 · Started: Feb 14, 2019

Contact the study team

• Sharon Sirota · Phone: +972545800765

Official record on ClinicalTrials.gov — NCT04699305

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.